AmoebaCompany research
Click on headlines below to download research
Fighting pathogens, respecting nature
Amoeba | 13/03/2023
During 2022 Amoéba secured regulatory approval in the United States and a recommendation for approval in the European Union for the active substance…
Executive interview
Amoeba – executive interview | 13/03/2023
Amoéba is developing biological fungicides for treating diseases such as mildews and rusts, which have a major economic impact on the production globally…